## CDW: CDW Corporation - XLK: Technology

### Executive Summary

No thesis match: MRS_20 -5.7% below STRENGTH zone (4.0-10.0%); PEG 1.53 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($127.62)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Templar Shield and CDW Announce Strategic Partnership**
- Source: Shreveport Times | 20260106T100800 | Bullish | Relevance: 100%
- Templar Shield and CDW have formed a strategic partnership to deliver global risk, security, OT, and AI governance solutions leveraging the ServiceNow AI Platform. This collaboration expands access to ServiceNow transformation solutions for CDW clients and combines CDW's global reach with Templar Shield's expertise, including their Flightpaths for Integrated Risk Management, Security Operations, AI Control Tower, and Operational Technology Management. The partnership aims to provide scalable ITx workflow delivery and comprehensive support across key risk and resiliency domains.

**2. Templar Shield and CDW Announce Strategic Partnership - Delmarva Now | The Daily Times**
- Source: DelmarvaNow.com | 20260106T090745 | Bullish | Relevance: 100%
- Templar Shield, a leader in risk management and cybersecurity, has formed a strategic partnership with CDW, a global IT solutions provider. This collaboration aims to expand access to ServiceNow risk and security transformation solutions globally, leveraging Templar Shield's expertise and CDW's extensive reach. The partnership will focus on delivering solutions for Integrated Risk Management, Security Operations, AI Governance, and Operational Technology Management, powered by Templar Shield's Flightpaths and VVET AIâ„¢ framework.

**3. Templar Shield and CDW Announce Strategic Partnership**
- Source: The Register-Guard | 20260106T080837 | Bullish | Relevance: 100%
- Templar Shield and CDW have formed a strategic partnership to broaden access to ServiceNow-based risk and security transformation solutions globally. This collaboration will allow Templar Shield to deliver services under CDW's contracting model, leveraging CDW's reach and Templar Shield's expertise in areas like Integrated Risk Management, Security Operations, and AI Governance. The partnership aims to accelerate modernization, automation, and resilience for clients worldwide.

**4. Templar Shield and CDW Announce Strategic Partnership - FDL Reporter | The Reporter**
- Source: www.fdlreporter.com | 20260106T080837 | Bullish | Relevance: 100%
- Templar Shield, an advisory and implementation firm specializing in risk management and cybersecurity, has partnered with CDW, a global IT solutions provider. This collaboration aims to expand access to ServiceNow risk and security transformation solutions globally, combining CDW's extensive reach with Templar Shield's expertise across the ServiceNow ecosystem. The partnership will deliver comprehensive ServiceNow Flightpaths covering Integrated Risk Management, Security Operations, AI Control Tower, and Operational Technology Management, enhancing capabilities for global clients.

**5. Templar Shield and CDW Announce Strategic Partnership**
- Source: The Fayetteville Observer | 20260106T080807 | Bullish | Relevance: 100%
- Templar Shield and CDW have formed a strategic partnership to enhance global access to ServiceNow risk and security transformation solutions. This collaboration leverages CDW's extensive global reach and Templar Shield's specialized expertise in risk management, cybersecurity, and AI governance, particularly on the ServiceNow AI Platform. The partnership aims to provide clients with advanced solutions for integrated risk management, security operations, AI governance, and operational technology risk.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $177 | $191 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 18 ($0.12M) |
| Sells | 5 ($1.19M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 13.2% (+2.2%)
- Blackrock Inc.: 9.2% (+8.2%)
- State Street Corpora: 4.5% (-0.4%)
- JPMORGAN CHASE & CO: 4.1% (+250.4%)
- Select Equity Group : 3.2% (+2.5%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.1% 5d) with bearish MACD, trend may be turning.
2. Long-term trend broken: trading 17.1% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.53 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 43%). Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($1.2M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $17.6B |
| Beta | 1.07 |
| 52W Range | $132.98 - $222.92 |
| Short Interest | 4.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.53 |
| Forward P/E | 12.7 |
| Current P/E | 13.6 |
| YoY Growth | 6.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -3.6% to -5.7% (-2.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 9.7pp (needs >4.0% for momentum thesis). AM_20 at -4.9% indicates price below own 20MA trend. Underperforming sector by 6.0pp, stock-specific weakness. Below SMA200 (0.83x), long-term trend not supportive. MACD histogram bearish (-0.71), momentum weakening. OFD pattern: +MUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -5.65% (CS: 4) | Weak |
| RSI_14 | 32.2 | Neutral |
| MACD Histogram | -0.71 | Bearish |
| vs SMA20 | 0.951x | Below |
| vs SMA50 | 0.931x | Below |
| vs SMA200 | 0.829x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $134.34
- **Stop Loss:** $127.62 (5.0% risk)
- **Target:** $141.06 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 163
- **Position Value:** $21,897.42
- **Portfolio %:** 21.90%
- **Risk Dollars:** $1,100.00
- **Risk Per Trade:** 1.10%
- **Modifiers:** L1 110% | L2 100% | Combined 1.10x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_ON (MEDIUM) | 1.10x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*RISK_ON regime with strong participation and low volatility. VIX at 14.75 (6th percentile) with breadth at 63.5% signals healthy risk appetite. Fed dovish expectations and AI/semiconductor momentum are primary drivers, though elevated put/call ratio suggests smart money hedging. Focus on quality growth with awareness of potential complacency.*

### Earnings

**Next:** 2026-02-11 (Est: $2.44)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.62 | $2.71 | +3.4% |
| 2025Q2 | $2.49 | $2.60 | +4.4% |
| 2025Q1 | $1.96 | $2.15 | +9.5% |
| 2024Q4 | $2.32 | $2.48 | +6.7% |

---
*RULE-based L3 | 2026-01-07 08:25 | MRS_20*